Lilly Obesity Drug Gets First US Approval for Sleep Apnea
- Posted on December 20, 2024
- By Bing News
- 2 Views
Lilly Obesity Drug Gets First US Approval for Sleep Apnea
Eli Lilly & Co.’s weight-loss shot Zepbound won approval in the US as the first drug to treat sleep apnea, opening the door for broader insurance coverage of the blockbuster medicine.
